
Kelpsceft SB 1000mg/500mg Injection
Marketer
Kelps Healthcare Private Limited
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Kelpsceft SB 1000mg/500mg Injection
Cephalexin and Sulbactam injection (1000mg/500mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth and halting infection progression. Administration must be under a doctor's direct supervision; strict adherence to the prescribed dosage schedule is vital. Complete the full course of treatment, even with symptom improvement; premature cessation can reduce effectiveness. Nausea, vomiting, diarrhea, and indigestion are potential side effects; consult your physician if they worsen. Seek immediate medical attention for allergic reactions such as rashes, itching, swelling, or breathing difficulties. Inform your doctor about all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally not impairing driving ability, avoid driving if experiencing drowsiness or dizziness. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order tests to monitor the treatment's impact.
Uses of Kelpsceft SB 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Kelpsceft SB 1000mg/500mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Kelpsceft SB 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Kelpsceft SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Kelpsceft SB 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Kelpsceft SB 1000mg/500mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, thereby hindering bacterial growth and survival. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concomitant alcohol and Kelpsceft SB 1000mg/500mg Injection use.
PregnancySAFE IF PRESCRIBED
The injectable medication Kelpsceft SB (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no harmful consequences for offspring; nevertheless, data from human trials remains scarce.
Breast feedingCAUTION
The administration of Kelpsceft SB 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Kelpsceft SB 1000mg/500mg Injection may induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kelpsceft SB 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Kelpsceft SB 1000mg/500mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Kelpsceft SB 1000mg/500mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Kelpsceft SB 1000mg/500mg Injection :
Omit doses of Kelpsceft SB 1000mg/500mg Injection only after contacting your physician.
Facts to Know About Kelpsceft SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
